Sunday, June 02, 2024 2:58:41 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent NRIX News
- Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff • PR Newswire (Canada) • 01/14/2026 03:52:00 PM
- Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff • PR Newswire (US) • 01/14/2026 03:52:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:34:04 PM
- Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases • GlobeNewswire Inc. • 01/12/2026 12:00:00 PM
- Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/05/2026 12:00:00 PM
- Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge • GlobeNewswire Inc. • 12/24/2025 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2025 11:08:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/18/2025 09:21:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2025 11:05:19 AM
- Nurix Therapeutics Presents New Data from the Phase 1 Trial of Bexobrutideg (NX-5948) in Waldenström Macroglobulinemia at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition • GlobeNewswire Inc. • 12/08/2025 01:00:00 PM
- Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Me • GlobeNewswire Inc. • 12/06/2025 02:30:00 PM
- Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial of BTK Degrader Bexobrutideg (NX-5948) To Be Presented at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition • GlobeNewswire Inc. • 12/01/2025 12:00:00 PM
- Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference • GlobeNewswire Inc. • 11/25/2025 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/24/2025 09:27:01 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2025 10:02:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 12:19:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 12:18:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:02 PM
- Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors • GlobeNewswire Inc. • 11/10/2025 12:00:00 PM
- Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling • GlobeNewswire Inc. • 11/07/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/04/2025 12:14:23 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/03/2025 09:27:15 PM
- Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 11/03/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2025 10:06:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2025 10:02:29 PM
Rainmaker Worldwide Inc. Announces Settlement Agreement Resolving Legacy Debt Obligation • RAKR • Jan 15, 2026 10:35 AM
Xalles Holdings Announces Management Changes • XALL • Jan 12, 2026 8:46 AM
One World Products Enters 2026 Positioned for Disciplined Growth as Isiah Enterprises • OWPC • Jan 8, 2026 12:22 PM
ConnectM Acquires 40% of Sun Solar, Strengthening Balance Sheet and Expanding National Solar & Storage Footprint in Multi-Billion Dollar U.S. Residential Solar & Storage Market • CNTM • Jan 7, 2026 9:00 AM
EVTV Executes Transformational AZIO AI Acquisition Framework at $3.00 Per Share • EVTV • Jan 6, 2026 7:00 AM
Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • FITY • Jan 5, 2026 1:00 PM
